US Stock MarketDetailed Quotes

APVO Aptevo Therapeutics

Watchlist
  • 0.6120
  • -0.0628-9.31%
Close Apr 28 16:00 ET
  • 0.6414
  • +0.0294+4.80%
Pre 05:35 ET
3.39MMarket Cap-0.01P/E (TTM)

About Aptevo Therapeutics Company

Aptevo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages on developing novel immunotherapies for the treatment of cancer. Its pipeline APVO436, ALG.APV-527, and APVO603 were developed based on the ADAPTIR modular protein platform technology and APVO442 was developed based on the new ADAPTIR-FLE platform technology. The ADAPTIR and ADAPTIR-FLEX are capable of generating differentiated bispecific and multi-specific antibodies with potentially unique mechanisms of action for the treatment of different types of cancer. The company was founded in February 2016 and is headquartered in Seattle, WA.

Company Profile

SymbolAPVO
Company NameAptevo Therapeutics
Listing DateJul 20, 2016
Issue Price3.71
Founded2016
CEOMr. Marvin L. White
MarketNASDAQ
Employees42
Fiscal Year Ends12-31
Address2401 4th Avenue,Suite 1050
CitySeattle
ProvinceWashington
CountryUnited States of America
Zip Code98121
Phone1-206-838-0500

Company Executives

  • Name
  • Position
  • Salary
  • Marvin L. White
  • Director, President and Chief Executive Officer
  • --
  • Daphne L. Taylor
  • Senior Vice President, Chief Financial Officer and Principal Accounting Officer
  • --
  • Jeffrey G. Lamothe
  • Executive Vice President and Chief Operating Officer
  • --
  • So Young Kwon
  • Senior Vice President, Business Development and Corporate Affairs and General Counsel
  • --
  • Dr. John E. Niederhuber, M.D.
  • Chairman of the Board
  • --
  • Barbara Lopez Kunz
  • Independent Director
  • --
  • Grady Grant, III
  • Independent Director
  • --
  • Daniel J. Abdun-Nabi
  • Independent Director
  • --
  • Dr. Zsolt Harsanyi,PhD
  • Independent Director
  • --

Market Insights

Tariff Storm Hits: Hedge with ETFs? Tariff Storm Hits: Hedge with ETFs?

The U.S. has sparked a tariff storm, triggering global market volatility. When the market fluctuates violently, more investment opportunities often appear. Compared with choosing individual stocks, investing in ETFs of the broader market can more easily capture opportunities for market reversals. Disclaimer: Among the U.S. stock market index ETFs: EFF, which is in the top 3 in terms of asset size among the fear index ETFs; the top 3 ETFs in terms of asset size among the S&P 500 index ETFs; and the corresponding leveraged ETFs; the top 4 ETFs in terms of asset size among the Nasdaq ETFs; and the top 3 ETFs in terms of asset size among the Dow Jones Index. This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors' financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal. FUTU makes no representation or warranty as to its adequacy, completeness, accuracy or timeline for any particular purpose of the above content. Instutional holding and portfolio information provided is based data in 13f filings. The composition provided is updated on a significant delay and may be incomplete. It is not possible to replicate the timing or exact holdings and portfolios. The U.S. has sparked a tariff storm, triggering global market volatility. When the market fluctuates violently, more investment opportunities often appear. Compared with choosing individual stocks, investing in ETFs of the broader market can more easily capture opportunities for market reversals. Disclaimer: Among the U.S. stock market index ETFs: EFF, which is in the top 3 in terms of asset size among the fear index ETFs; the top 3 ETFs in terms of asset size among the S&P 500 index ETFs; and the corresponding leveraged ETFs; the top 4 ETFs in terms of asset size among the Nasdaq ETFs; and the top 3 ETFs in terms of asset size among the Dow Jones Index. This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors' financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal. FUTU makes no representation or warranty as to its adequacy, completeness, accuracy or timeline for any particular purpose of the above content. Instutional holding and portfolio information provided is based data in 13f filings. The composition provided is updated on a significant delay and may be incomplete. It is not possible to replicate the timing or exact holdings and portfolios.

Unlock Now

Discussing

關稅風暴暫離高壓區!市場能否迎來反彈?
當地時間4月22日,美國總統特朗普公開承認美國目前對中國出口商品的關稅過高,預計稅率將大幅降低;美國財政部長貝森特也表示中美雙方關稅戰將很快降溫。4月25日,特朗普表示將爲不同國家設定「公平的」關稅稅率。特朗普此次對華關稅態度的轉變,能否平息市場恐慌情緒?關稅拉鋸戰最終結局如何? Show More

focus on technology stocks

Top tech company strong as always.